27 results · Page 1 of 2

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)Progressive Metastatic Castrate Resistant Prostate CancerRecruitingPhase 1 / Phase 22026-10-09NCT07206056
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset SeizuresNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Focal, Signs and Symptoms, nervous system disorder, visual epilepsyRecruitingPhase 12026-10-02NCT07233239
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 22026-10-02NCT06680830
JAK Signaling in Depression and Cognition in Male Football PlayersInflammation, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, depressive disorder, nervous system disorderRecruitingPhase 22026-09-24NCT07608796
Bionic Pancreas in CFRDcystic fibrosis-related diabetesActive, not recruitingPhase 32026-09-18NCT06449677
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesCNS demyelinating autoimmune disease, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, acute stress disorder, adjustment disorder, amyotrophic lateral sclerosis, anxiety disorder, autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, demyelinating disease, depressive disorder, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, metabolic disease, motor neuron disorder, multiple sclerosis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, psychiatric disorder, pulmonary fibrosis, respiratory system disorder, spinal cord disorderRecruitingPhase 22026-09-15NCT07002034
Metformin in Alzheimer's Dementia PreventionCognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorderActive, not recruitingPhase 2 / Phase 32026-08-11NCT04098666
Thrive With Type 1 Diabetes 2026Type1diabetesRecruitingNot applicable2026-08-06NCT07522866
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationAlzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyRecruitingPhase 2 / Phase 32026-07-27NCT06647498
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationAlzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyRecruitingPhase 2 / Phase 32026-07-27NCT05552157
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyActive, not recruitingPhase 2 / Phase 32026-07-27NCT05269394
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyActive, not recruitingPhase 2 / Phase 32026-07-27NCT01760005
Inspiring Seniors Towards Exercise Promotion - 2Old AgeRecruitingNot applicable2026-07-23NCT07629739
Psilocybin for Major Depressive Disorder (MDD)depressive disorder, major depressive disorder, mood disorder, psychiatric disorderActive, not recruitingPhase 32026-07-23NCT06308653
Voice Technology-Based Self-Management InterventionCognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorderRecruitingNot applicable2026-07-07NCT06982261
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyNot yet recruitingNot applicable2026-06-30NCT07675408
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal ConditionsMulti-Level Degenerative Lumbosacral Spinal ConditionsActive, not recruitingNot applicable2026-06-25NCT03118505
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PLacquired partial lipodystrophy, partial lipodystrophyActive, not recruitingPhase 32026-06-15NCT05164341
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagementautism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorderRecruitingNot stated2026-06-04NCT05916430
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidEarly Preclinical Alzheimer's Disease; Preclinical Alzheimer's DiseaseActive, not recruitingPhase 32026-06-04NCT04468659
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding DifficultyInfant Nutrition Disorders, Nutritional and Metabolic Diseases, nutritional disorderRecruitingNot applicable2026-05-27NCT04599010
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, Withdrawal Symptoms, opiate dependence, psychiatric disorder, substance withdrawal syndrome, substance-related disorderRecruitingPhase 32026-03-27NCT05834478
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)Pathologic Processes, Pathological Conditions, Signs and Symptoms, pulmonary emphysemaActive, not recruitingPhase 22026-01-26NCT05382208
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophyautonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, hypotensive disorder, movement disorder, multiple system atrophy, nervous system disorder, primary dysautonomia, vascular disorderActive, not recruitingPhase 32025-09-05NCT05696717
LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosisbone disorder, lumbar spinal stenosis, musculoskeletal system disorder, spinal stenosis, vertebral column disorderActive, not recruitingNot applicable2025-08-07NCT03115983